Abstract
Depression is one of the most prevalent severe CNS disorders, which negatively affects social lives, the ability to work, and the health of people. As per the World Health Organisation (WHO), it is a psychological disorder that is estimated to be a leading disease by 2030. Clinically, various medicines have been formulated to treat depression but they are having a setback due to their side effects, slow action, or poor bioavailability. Nowadays, flavonoids are regarded as an essential component in a variety of nutraceutical, pharmaceutical and medicinal. Isoflavones are a distinctive and important subclass of flavonoids that are generally obtained from soybean, chickpeas, and red clover. The molecules of this class have been extensively explored in various CNS disorders including depression and anxiety. Isoflavones such as genistein, daidzein, biochanin-A, formononetin, and glycitein have been reported to exert an anti-depressant effect through the modulation of different mediators. Fatty acid amide hydrolase (FAAH) mediated depletion of anandamide and hypothalamic-pituitary-adrenal (HPA) axis-mediated modulation of brain-derived neurotrophic factor (BDNF), monoamine oxidase (MAO) mediated depletion of biogenic amines and inflammatory signaling are the important underlying pathways leading to depression. Upregulation in the levels of BDNF, anandamide, antioxidants and monoamines, along with inhibition of MAO, FAAH, HPA axis, and inflammatory stress are the major modulations produced by different isoflavones in the observed anti-depressant effect. Therefore, the present review has been designed to explore the mechanistic interplay of various mediators involved in mediating the anti-depressant action of different isoflavones.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Not applicable.
Code availability
Not applicable.
References
Acquaviva R, Malfa GA, Giacomo CD (2021) Plant-based bioactive molecules in improving Health and preventing Lifestyle Diseases. Int J Mol Sci 22(6):2991. https://doi.org/10.3390/ijms22062991
Albert PR (2015) Why is depression more prevalent in women? J Psychiatry Neurosci 40(4):219–221
Alger BE (2004) Endocannabinoids: getting the message across. Proc Natl Acad Sci U S A 101(23):8512–8513. https://doi.org/10.1073/pnas.0402935101
Ali S, Corbi G, Maes M, Scapagnini G, Davinelli S (2021) Exploring the impact of flavonoids on symptoms of depression: a systematic review and meta-analysis. Antioxidants 10(11):1644
Anacker C, Zunszain PA, Carvalho LA, Pariante CM (2011) The glucocorticoid receptor: pivot of depression and of anti-depressant treatment? Psychoneuroendocrinology 36(3):415–425
Atteritano M, Mazzaferro S, Bitto A, Cannata ML, Anna RD, Squadrito F, Macri I, Frisina A, Frisina N, Bagnato G (2014) Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study. Osteoporos Int 25(3):1123–1129. https://doi.org/10.1007/s00198-013-2512-5
Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G, Ciora FL, Toma MM, Bungau S, Bumbu AG (2021) Role of Monoamine Oxidase Activity in Alzheimer’s Disease: an insight into the therapeutic potential of inhibitors. Molecules 26(12):3724. https://doi.org/10.3390/molecules26123724
Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN (1994) Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 51(9):687–697. https://doi.org/10.1001/archpsyc.1994.03950090019003
Biradar SM, Joshi H, Chheda TK (2014) Biochanin-A ameliorates behavioural and neurochemical derangements in cognitive-deficit mice for the betterment of Alzheimer’s disease. Hum Exp Toxicol 33(4):369–382. https://doi.org/10.1177/0960327113497772
Brigitta B (2002) Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci 4(1):7–20. https://doi.org/10.31887/DCNS.2002.4.1/bbondy
Carnevali L, Statello R, Vacondio F, Ferlenghi F, Spadoni G, Rivara S, Mor M, Sgoifo A (2020) Anti-depressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats. Eur Neuropsychopharmacol 32:77–87. https://doi.org/10.1016/j.euroneuro.2019.12.119
Chang M, Zhang L, Dai H, Sun L (2021) Genistein acts as anti-depressant agent against chronic mild stress-induced depression model of rats through augmentation of brain-derived neurotrophic factor. Brain Behav 11(8):e2300. https://doi.org/10.1002/brb3.2300
Chen HQ, Wang XJ, Jin ZY, Xu XM, Zhao JW, Xie ZJ (2008) Protective effect of isoflavones from Trifolium pratense on dopaminergic neurons. Neurosci Res 62(2):123–130. https://doi.org/10.1016/j.neures.2008.07.001
Chen L, Wang X, Zhang Y, Zhong H, Wang C, Gao P, Li B (2021) Daidzein alleviates hypothalamic-pituitary-adrenal Axis hyperactivity, ameliorates depression-like behavior, and partly rectifies circulating cytokine imbalance in two rodent models of depression. Front Behav Neurosci 15:178. https://doi.org/10.3389/fnbeh.2021.671864
Chiuccariello L, Houle S, Miler L, Cooke RG, Rusjan PM, Rajkowska G, Levitan RD, Kish SJ, Kolla NJ, Ou X, Wilson AA, Meyer JH (2014) Elevated monoamine oxidase a binding during major depressive episodes is associated with greater severity and reversed neurovegetative symptoms. Neuropsychopharmacology 39(4):973–980. https://doi.org/10.1038/npp.2013.297
Čižmárová B, Hubková B, Tomečková V, Birková A (2023) Flavonoids as promising natural compounds in the prevention and treatment of selected skin diseases. Int J Mol Sci 24(7):6324
Clarke DB, Bailey V, Lloyd AS (2008) Determination of phytoestrogens in dietary supplements by LC-MS/MS. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25(5):534–547. https://doi.org/10.1080/02652030701658340
Correia AS, Cardoso A, Vale N (2023) Oxidative stress in depression: the link with the stress response, neuroinflammation, serotonin, neurogenesis and synaptic plasticity. Antioxidants 12(2):470
Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46–56. https://doi.org/10.1038/nrn2297
de Oliveira SR, Taveira SF, Marreto RN, Valadares MC, Diniz DG, Lima EM (2013) Preparation and characterization of solid oral dosage forms containing soy isoflavones. Rev Bras 23(1):175–181
Delgado PL (2000) Depression: the case for a monoamine deficiency. J Clin Psychiatry 6:7–11
Di Marzo V, Maccarrone M (2008) FAAH and anandamide: is 2-AG really the odd one out? Trends Pharmacol Sci 29(5):229–233. https://doi.org/10.1016/j.tips.2008.03.001
Dias MC, Pinto DCGA, Silva AMS (2021) Plant flavonoids: chemical characteristics and biological activity. Molecules 26(17):5377. https://doi.org/10.3390/molecules26175377
Ferguson JM (2001) SSRI anti-depressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry 3(1):22–27. https://doi.org/10.4088/pcc.v03n0105
Fries GR, Saldana VA, Finnstein J, Rein T (2023) Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry 28(1):284–297
Gaweska H, Fitzpatrick PF (2011) Structures and mechanism of the Monoamine Oxidase Family. Biomol Concepts 2(5):365–377. https://doi.org/10.1515/BMC.2011.030
Glassman AH (1984) Cardiovascular effects of tricyclic anti-depressants. Annu Rev Med 35(1):503–511. https://doi.org/10.1146/annurev.me.35.020184.002443
Goethe JW, Woolley SB, Cardoni AA, Woznicki BA, Piez DA (2007) Selective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherence. J Clin Psychopharmacol 27(5):451–458. https://doi.org/10.1097/jcp.0b013e31815152a5
Gordon JL, Girdler SS (2014) Hormone replacement therapy in the treatment of perimenopausal depression. Curr Psychiatry Rep 16:1–7
Gorzkiewicz J, Bartosz G, Sadowska BI (2021) The potential effects of phytoestrogens: the role in Neuroprotection. Molecules 26(10):2954. https://doi.org/10.3390/molecules26102954
Guo M, Lu H, Qin J, Qu S, Wang W, Guo Y, Liao W, Song M, Chen J, Wang Y (2019) Biochanin A provides Neuroprotection Against Cerebral Ischemia/Reperfusion Injury by Nrf2-Mediated inhibition of oxidative stress and inflammation signaling pathway in rats. Med Sci Monit 25:8975–8983. https://doi.org/10.12659/MSM.918665
Gupta G, Tay JJ, Woon LY, Chellapan DK, Candasamy M, Dua K (2015) Pharmacological evaluation of anti-depressant-like effect of genistein and its combination with amitriptyline: an acute and chronic study. Adv Pharmacol Sci 2015:164943. https://doi.org/10.1155/2015/164943
Gutierrez ZA, Santell R, Wu Z, Brown M, Wu Y, Khan I, Link CD, Zhao B (2005) Luo Y (2005) Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci 6:54. https://doi.org/10.1186/1471-2202-6-54
Hansson AC, Cintra A, Belluardo N, Sommer W, Bhatnagar W, Bader M, Ganten D, Fuxe K (2000) Gluco- and mineralocorticoid receptor-mediated regulation of neurotrophic factor gene expression in the dorsal hippocampus and the neocortex of the rat. Eur J Neurosci 12(8):2918–2934. https://doi.org/10.1046/j.1460-9568.2000.00185.x
Hill AR, Spencer-Segal JL (2021) Glucocorticoids and the brain after critical illness. Endocrinology 162(3):bqaa242
Hu P, Li M, Wang YG, Ye F, Wang C, Zhou WH, Zhao X (2017) Genistein, a dietary soy isoflavone, exerts anti-depressant-like effects in mice: involvement of serotonergic system. Neurochem Int 108:426–435. https://doi.org/10.1016/j.neuint.2017.06.002
Ionescu TA, Tong L, Berchtold NC, Cotman CW (2022) Inhibiting BDNF signaling upregulates hippocampal H3K9me3 in a Manner Dependent on in Vitro Aging and oxidative stress. Front Aging 3:796087. https://doi.org/10.3389/fragi.2022.796087
Ishiwata N, Melby MK, Mizuno S, Watanabe S (2009) New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of japanese women. Menopause 16(1):141–148. https://doi.org/10.1097/gme.0b013e31818379fa
Jeanneteau F, Chao MV (2013) Are BDNF and glucocorticoid activities calibrated? Neuroscience 239:173–195. https://doi.org/10.1016/j.neuroscience.2012.09.017
Jiang HX, Ke BW, Liu J, Ma G, Hai KR, Gong DY, Yang Z, Zhou C (2022) Inhibition of fatty acid Amide Hydrolase improves depressive-like behaviors independent of its peripheral antinociceptive effects in a rat model of neuropathic pain. Anesth Analg 129(2):587–597. https://doi.org/10.1213/ANE.0000000000003563
Jin PS, Kun Q (2011) Effect of daidzein on behavior and brain-derived neurotrophic factor of Hippocampus in rats with chronic stress depression. Herald Med 30(4):446–449. https://doi.org/10.3870/yydb.2011.04.011
Ju YH, Fultz J, Allred KF, Doerge DR, Helferich WG (2006) Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis 27(4):856–863
Kageyama A, Sakakibara H, Zhou W, Yoshioka M, Ohsumi M, Shimoi K, Yokogoshi H (2010) Genistein regulated serotonergic activity in the hippocampus of ovariectomized rats under forced swimming stress. Biosci Biotechnol Biochem 74(10):2005–2010. https://doi.org/10.1271/bbb.100238
Kalsi R (2021) Role of flavonoids. Pharmacol Aspect 2(5):11–12
Kesarwani K, Gupta R (2013) Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed 3(4):253–266
Kino T, Jaffe H, Amin ND, Chakrabarti M, Zheng YL, Chrousos GP, Pant HC (2010) Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor. Mol Endocrinol 24(5):941–952. https://doi.org/10.1210/me.2009-0395
Ko YH, Kim SK, Lee SY, Jang CG (2020) Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression. Arch Pharm Res 43(11):1128–1143. https://doi.org/10.1007/s12272-020-01292-5
Křížová L, Dadáková K, Kašparovská J, Kašparovský T (2019) Isoflavones. Molecules 24(6):1076. https://doi.org/10.3390/molecules24061076
Laddha AP, Murugesan S, Kulkarni YA (2022) In-vivo and in-silico toxicity studies of daidzein: an isoflavone from soy. Drug Chem Toxicol 45(3):1408–1416
Li P, Li M, Lou X, Zhao B, Ma Q, Bian Y, Mi X (2022) Evaluation of hypoglycemic activity and sub-acute toxicity of the Novel Biochanin A–Chromium (III) complex. Molecules 27(18):5786
Lipovac M, Chedraui P, Gruenhut C, Gocan A, Stammler M, Imhof M (2010) Improvement of postmenopausal depressive and anxiet + y symptoms after treatment with isoflavones derived from red clover extracts. Maturitas 65(3):258–261. https://doi.org/10.1016/j.maturitas.2009.10.014
Liu W, Ge T, Leng Y, Pan Z, Fan J, Yang W, Cui R (2017) The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast 2017:6871089. https://doi.org/10.1155/2017/6871089
Luo LY, Fan MX, Zhao HY, Li MX, Wu X, Gao WY (2018) Pharmacokinetics and bioavailability of the isoflavones formononetin and ononin and their in vitro absorption in using chamber and Caco-2 cell models. J Agric Food Chem 66(11):2917–2924
Mamagkaki A, Bouris I, Parsonidis P, Vlachou I, Gougousi M, Papasotiriou I (2021) Genistein as a dietary supplement; formulation. Anal Pharmacokinet Stud 16(4):e0250599
Maria B, Gofita E, Calina DC, Stiolica AT, Docea AO, Balseanu TA, Camen A, Popa EG, Rusu G, Cristofor I, Pavel L, Tartau LM (2017) New anti-depressant medication: benefits versus adverse Effects. INTECH. https://doi.org/10.5772/intechopen.72003
Marken PA, Munro JS (2000) Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features. Prim Care Companion J Clin Psychiatry 2(6):205–210. https://doi.org/10.4088/pcc.v02n0602
Martín-González C, González-Arnay E, Fernández-Rodríguez CM, García-Rodríguez A, González-Reimers E (2022) Alcohol and brain-derived neurotrophic factor (BDNF). Handbook of Substance Misuse and Addictions. Springer, Cham. https://doi.org/10.1007/978-3-030-92392-1_182
McEwen BS, Conrad CD, Kuroda Y, Frankfurt M, Magarinos AM, McKittrick C (1997) Prevention of stress-induced morphological and cognitive consequences. Eur Neuropsychopharmacol 1:S323–S328
Messina M (2016) Soy and health update: evaluation of the clinical and epidemiologic literature. Nutrients 8(12):754. https://doi.org/10.3390/nu8120754
Moon YJ, Sagawa K, Frederick K, Zhang S, Morris ME (2006) Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats. AAPS J 8(3):E433–E442. https://doi.org/10.1208/aapsj080351
Mrozek W, Socha J, Sidorowicz K, Skrok A, Syrytczyk A, Piątkowska-Chmiel I, Herbet M (2023) Pathogenesis and treatment of depression: role of diet in prevention and therapy. Nutrition 115:112143
Nachimuthu S, Assar MD, Schussler JM (2012) Drug-induced QT interval prolongation: mechanisms and clinical management. Ther Adv Drug Saf 5:241–253. https://doi.org/10.1177/2042098612454283
Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH (2007) Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology 192(1):61–70. https://doi.org/10.1007/s00213-006-0689-4
Naveen GH, Varambally S, Thirthalli J, Rao M, Christopher R, Gangadhar BN (2016) Serum cortisol and BDNF in patients with major depression-effect of yoga. Int Rev Psychiatry 28(3):273–278. https://doi.org/10.1080/09540261.2016.1175419
Nicholas A, Munhoz CD, Ferguson D, Campbell L, Sapolsky R (2006) Enhancing cognition after stress with gene therapy. J Neurosci 26(45):11637–11643. https://doi.org/10.1523/JNEUROSCI.3122-06
Nobile B, Ramoz N, Jaussent I, Gorwood P, Olie E, Castroman JL, Guillaume S, Courtet P (2019) Polymorphism A118G of opioid receptor mu 1 (OPRM1) is associated with emergence of suicidal ideation at anti-depressant onset in a large naturalistic cohort of depressed outpatients. Sci Rep 9(1):2569. https://doi.org/10.1038/s41598-019-39622-3
Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci 5:e47. https://doi.org/10.1017/jns.2016.41
Pejčić T, Zeković M, Bumbaširević U, Kalaba M, Vovk I, Bensa M, Popović L, Tešić Ž (2023) The role of isoflavones in the prevention of breast cancer and prostate cancer. Antioxidants 12(2):368
Petrovska BB (2012) Historical review of medicinal plants’ usage. Pharmacogn Rev 6(11):1–5. https://doi.org/10.4103/0973-7847.95849
Pietta PG (2000) Flavonoids as antioxidants. J Nat Prod 63(7):1035–1042. https://doi.org/10.1021/np9904509
Pingale TD, Gupta GL (2023) Acute & sub-acute toxicity study reveals no dentrimental effect of formononetin in mice upon repeated ip dosing. Toxicol Mech Methods 33(8):688–697. https://doi.org/10.1080/15376516.2023.2234026
Prabhakar D, Sablaban I (2019) Escitalopram-induced rash. Prim Care Companion CNS Disord 21(1):18l02302. https://doi.org/10.4088/PCC.18l02302
Prajapati R, Park SE, Park HJ, Jung SC, Choi JS (2021) Identification of a potent and selective human monoamine oxidase-A inhibitor, glycitein, an isoflavone isolated from Pueraria lobata flowers. ACS Food Sci Technol 1(4):538–550
Qasim QA, Alsaad AA, Al-Salman HN (2021) In-vivo and in-vitro evaluation for memory enhancing activity of some isoflavonoids by suitable animal models. J Chem Health Risks 11(3):305–315
Rai D, Zitko P, Jones K, Lynch J, Araya R (2013) Country-and individual-level socioeconomic determinants of depression: multilevel cross-national comparison. Br J Psychiatry 202(3):195–203
Rana T, Behl T, Sehgal A, Mehta V, Singh S, Kumar R, Bungau S (2021) Integrating endocannabinoid signalling in depression. J Mol Neurosci 71(10):2022–2034. https://doi.org/10.1007/s12031-020-01774-7
Rosen RC, Lane RM, Menza M (1999) Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 19(1):67–85. https://doi.org/10.1097/00004714-199902000-00013
Salik I, Marwaha R (2022) Electroconvulsive Therapy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, PMID: 30855854
Santomauro DF, Herrera AM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, Abbafati C, Adolph C, Amlag JO, Aravkin AY, Bang-Jensen BL (2021) Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 398(10312):1700–1712. https://doi.org/10.1016/S0140-6736(21)02143-7
Sarfraz A, Javeed M, Shah MA, Hussain G, Shafiq N, Sarfraz I, Riaz A, Sadiqa A, Zara R, Zafar S, Kanwal L (2020) Biochanin A: a novel bioactive multifunctional compound from nature. Sci Total Environ 722:137907
Sarfraz I, Rasul A, Riaz A, Ucak I, Zahoor MK, Hussain G, Nawaz J, Sadiqa A, Adem Ş (2021) Biochanin A and biochanin B. A Centum of Valuable Plant Bioactives. Academic Press. https://doi.org/10.1016/B978-0-12-822923-1.00031-5
Sathyanarayana RT, Yeragani VK (2009) Hypertensive crisis and cheese. Indian J Psychiatry 51(1):65–66. https://doi.org/10.4103/0019-5545.44910
Seong SH, Kim BR, Cho ML, Kim TS, Im S, Han S, Jeong JW, Jung HA, Choi JS (2022) Phytoestrogen Coumestrol selectively inhibits Monoamine Oxidase-A and amyloid β self-aggregation. Nutrients 14(18):3822. https://doi.org/10.3390/nu14183822
Shao X, Zhu G (2020) Associations among Monoamine Neurotransmitter Pathways, personality traits, and major depressive disorder. Front Psychiatry 11:381. https://doi.org/10.3389/fpsyt.2020.00381
Shively CA, Register TC, Friedman DP, Morgan TM, Thompson J, Lanier T (2005) Social stress-associated depression in adult female cynomolgus monkeys (Macaca fascicularis). Biol Psychol 69(1):67–84
Silver RJ (2019) The endocannabinoid system of animals. Animals 9(9):686
Singh P, Sharma S, Kumar Rath S (2014) Genistein induces deleterious effects during its acute exposure in swiss mice. Biomed Res Int 2014:619617. https://doi.org/10.1155/2014/619617
Smith K (2014) Mental health: a world of depression. Nature 515(7526):180–181. https://doi.org/10.1038/515180a
Smith MA, Makino S, Kvetnansky R, Post RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15(3):1768–1777. https://doi.org/10.1523/JNEUROSCI.15-03-01768
Sousa RL, Filizola RG, Diniz MFFM, Sousa ESS, Moraes JLR (2006) Ensaio clínico placebo-controlado com isoflavonas da soja para sintomas depressivos em mulheres no climatério. Rev Bras Ginecol Obstet 28(2):91–100. https://doi.org/10.1590/S0100-72032006000200004
Spore KA (1995) The serotonin syndrome. Drug Saf 13(2):94–104. https://doi.org/10.2165/00002018-199513020-00004
Subramoniam A (2014) Present scenario, challenges and future perspectives in plant based medicine development. Ann Phytomed 3(1):31–36
Suneson K, Lindahl J, Chamli Hårsmar S, Söderberg G, Lindqvist D (2021) Inflammatory depression-mechanisms and non-pharmacological interventions. Int J Mol Sci 22(4):1640. https://doi.org/10.3390/ijms22041640
Tarzia G, Duranti A, Gatti G, Piersanti G, Tontini A, Rivara S, Lodola A, Plazzi PV, Mor M, Kathuria S, Piomelli D (2006) Synthesis and structure–activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring. Chem Med Chem: Chem Enabling Drug Discov 1(1):130–139
Tejeda-Martínez AR, Viveros-Paredes JM, Hidalgo-Franco GV, Pardo-Gonzalez E, Chaparro-Huerta V, Gonzalez-Castaneda RE, Flores-Soto ME (2021) Chronic inhibition of FAAH reduces depressive-like behavior and improves dentate gyrus proliferation after chronic unpredictable stress exposure. Behav Neurol 2021:6651492. https://doi.org/10.1155/2021/6651492
Thase ME (1998) Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 59(10):502–508. https://doi.org/10.4088/jcp.v59n1002
Thase ME, Nierenberg AA, Keller MB, Panagides J (2001) Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients. J Clin Psychiatry 62(10):782–788. https://doi.org/10.4088/jcp.v62n1006
Thors L, Eriksson J, Fowler CJ (2007) Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. Br J Pharmacol 152(5):744–750
Tian Y, Yuan W, Ma Q, Du Z, Li W (2015) Effects of daidzein on expressions of BDNF and NPY in hippocampus rats with chronic stress depression and non-specific immune regulation. Chin J Immunol 2015(12):632–637
Tolleson WH, Doerge DR, Churchwell MI, Marques MM, Roberts DW (2002) Metabolism of biochanin A and formononetin by human liver microsomes in vitro. J Agric Food Chem 50(17):4783–4790
Ullah A, Munir S, Badshah SL, Khan N, Ghani L, Poulson BG, Emwas AH, Jaremko M (2020) Important flavonoids and their role as a therapeutic Agent. Molecules 25(22):5243. https://doi.org/10.3390/molecules25225243
Varghese FP, Brown ES (2001) The hypothalamic-pituitary-adrenal Axis in major depressive disorder: a brief primer for primary care physicians. Prim Care Companion J Clin Psychiatry 3(4):151–155. https://doi.org/10.4088/pcc.v03n0401
Wang Y, Zhang X (2017) FAAH inhibition produces anti-depressant-like efforts of mice to acute stress via synaptic long-term depression. Behav Brain Res 324:138–145. https://doi.org/10.1016/j.bbr.2017.01.054
WHO (2022) Depression disorder (depression). https://www.who.int/news-room/fact-sheets/detail/depression
Wu WY, Wu YY, Huang H, He C, Li WZ, Wang HL, Chen HQ, Yin YY (2015) Biochanin A attenuates LPS-induced pro-inflammatory responses and inhibits the activation of the MAPK pathway in BV2 microglial cells. Int J Mol Med 35(2):391–398. https://doi.org/10.3892/ijmm.2014.2020
Yang T, Nie Z, Shu H, Kuang Y, Chen X, Cheng J, Yu S, Liu H (2020) The role of BDNF on neural plasticity in Depression. Front Cell Neurosci 14:82. https://doi.org/10.3389/fncel.2020.00082
Yang J, Shen H, Mi M, Qin Y (2023) Isoflavone consumption and risk of breast Cancer: an updated systematic review with meta-analysis of observational studies. Nutrients 15(10):2402
Yang Z, Zhu W, Gao S, Xu H, Wu B, Kulkarni K, Singh R, Tang L, Hu M (2010) Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC–MS/MS method: application to an oral bioavailability study of genistein in mice. J Pharm Biomed Anal 53(1):81–89. https://doi.org/10.1016/j.jpba.2010.03.011
Yangzom P, Amruthanand S, Sharma M, Mahajan S, Lingaraju MC, Parida S, Sahoo M, Kumar D, Singh TU (2022) Subacute 28 days oral toxicity study of kaempferol and biochanin-A in the mouse model. J Biochem Mol Toxicol 36(8):e23090
Yu S, Guo X, Yang H, Zheng L, Sun Y (2015) Soybeans or soybean products consumption and depressive symptoms in older residents in rural Northeast China: a cross-sectional study. J Nutr Health Aging 19(9):884–893. https://doi.org/10.1007/s12603-015-0517-9
Yuan B, Wang L, Jin Y, Zhen H, Xu P, Xu Y, Li C, Xu H (2012) Role of metabolism in the effects of genistein and its phase II conjugates on the growth of human breast cell lines. AAPS J 14:329–344
Zada W, VanRyzin JW, Pouchoulen PM, Baglot SL, Hill MN, Abbas G, Clark SM, Rashid U, McCarthy MM, Mannan A (2022a) Fatty acid amide hydrolase inhibition and N-arachidonoylethanolamine modulation by isoflavonoids: a novel target for upcoming anti-depressants. Pharmacol Res Perspect 10(5):e00999. https://doi.org/10.1002/prp2.999
Zada W, Murtaza G, Iqbal G, Abbas G, Khan SA, Mannan A (2022b) Antidepressant potential of daidzein through modulation of endocannabinoid system by targeting fatty acid amide hydrolase. Sains Malaysiana 51(10):3383–3399
Zarmouh NO, Eyunni SK, Soliman KF (2017) The benzopyrone biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor. BMC Complement Altern Med 17(1):1–3. https://doi.org/10.1186/s12906-016-1525-y
Zarmouh NO, Messeha SS, Elshami FM, Soliman KF (2016) Evaluation of the isoflavone genistein as reversible human monoamine oxidase-A and -B Inhibitor. Evid Based Complement Alternat Med 2016:1423052. https://doi.org/10.1155/2016/1423052
Zhang JR, Sun DL, Shi JJ, Zhao JM (2015) Antidepressive-like effect of daidzein in rats and its mechanism. Chin J New Drugs 24:1531–1536
Zhang C, Zhu L, Lu S, Li M, Bai M, Li Y, Xu E (2022) The anti-depressant-like effect of formononetin on chronic corticosterone-treated mice. Brain Res 1783:147844. https://doi.org/10.1016/j.brainres.2022.147844
Zhou S, Hu Y, Zhang B, Teng Z, Gan H, Yang Z, Wang Q, Huan M, Mei Q (2008) Dose-dependent absorption, metabolism, and excretion of genistein in rats. J Agric Food Chem 56(18):8354–8359. https://doi.org/10.1021/jf801051d
Zubik L, Meydani M (2003) Bioavailability of soybean isoflavones from aglycone and glucoside forms in american women. Am J Clin Nutr 77(6):1459–1465. https://doi.org/10.1093/ajcn/77.6.1459
Funding
None.
Author information
Authors and Affiliations
Contributions
Diksha has carried out the literature survey and wrote the manuscript. Dr. Lovedeep Singh has conceptualized and designed the idea; and also done the revision and language editing. Deepika Bhatia designed the figures.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
All authors declare no conflicts of interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Diksha, Singh, L. & Bhatia, D. Mechanistic interplay of different mediators involved in mediating the anti-depressant effect of isoflavones. Metab Brain Dis 39, 199–215 (2024). https://doi.org/10.1007/s11011-023-01302-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-023-01302-7